Birdwatch Note
2023-06-16 12:43:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Il est avéré que l’utilisation d’HCQ n’est pas efficace dans le traitement du COVID-19 : https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 En plus d’induire une surmortalité chez les patients traités : https://www.nature.com/articles/s41467-021-22446-z#:~:text=This%20collaborative%20meta%2Danalysis%20of,benefit%20from%20treatment%20with%20CQ. Enfin, Pr Raoult est accusé de fraude par la communauté scientifique sur des publications avérées falsifiées : https://www.sudouest.fr/france/didier-raoult-etudes-truquees-pressions-protections-les-revelations-de-complement-d-enquete-13020074.php
Written by 613A826ADB52E21743E4C50BA871F9C561D0A09F1A878E2B9FCF410A50F190F8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1669417193669312541
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1669687066442047491
- noteId - 1669687066442047491
- participantId -
- noteAuthorParticipantId - 613A826ADB52E21743E4C50BA871F9C561D0A09F1A878E2B9FCF410A50F190F8 Participant Details
- createdAtMillis - 1686919392581
- tweetId - 1669417193669312541
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Il est avéré que l’utilisation d’HCQ n’est pas efficace dans le traitement du COVID-19 : https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 En plus d’induire une surmortalité chez les patients traités : https://www.nature.com/articles/s41467-021-22446-z#:~:text=This%20collaborative%20meta%2Danalysis%20of,benefit%20from%20treatment%20with%20CQ. Enfin, Pr Raoult est accusé de fraude par la communauté scientifique sur des publications avérées falsifiées : https://www.sudouest.fr/france/didier-raoult-etudes-truquees-pressions-protections-les-revelations-de-complement-d-enquete-13020074.php
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-06-16 12:43:12 UTC (1686919392581) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-19 02:10:03 UTC (1687140603698) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-06-17 09:34:08 -0500 | Rating Details | |
| 2023-06-17 02:46:19 -0500 | Rating Details | |
| 2023-06-17 02:00:38 -0500 | Rating Details | |
| 2023-06-17 02:00:33 -0500 | Rating Details | |
| 2023-06-17 01:47:38 -0500 | Rating Details | |
| 2023-06-17 00:03:52 -0500 | Rating Details | |
| 2023-06-16 23:57:51 -0500 | Rating Details | |
| 2023-06-16 23:24:57 -0500 | Rating Details | |
| 2023-06-16 20:56:38 -0500 | Rating Details | |
| 2023-06-16 20:33:13 -0500 | Rating Details | |
| 2023-06-16 18:51:05 -0500 | Rating Details | |
| 2023-06-16 18:38:50 -0500 | Rating Details | |
| 2023-06-16 17:56:13 -0500 | Rating Details | |
| 2023-06-16 17:17:46 -0500 | Rating Details | |
| 2023-06-16 16:46:27 -0500 | Rating Details | |
| 2023-06-16 16:44:56 -0500 | Rating Details | |
| 2023-06-16 15:57:20 -0500 | Rating Details | |
| 2023-06-16 15:28:01 -0500 | Rating Details | |
| 2023-06-16 15:17:43 -0500 | Rating Details | |
| 2023-06-16 14:43:45 -0500 | Rating Details | |
| 2023-06-16 14:39:44 -0500 | Rating Details | |
| 2023-06-16 14:33:10 -0500 | Rating Details | |
| 2023-06-16 14:26:48 -0500 | Rating Details | |
| 2023-06-16 14:23:24 -0500 | Rating Details | |
| 2023-06-16 14:22:44 -0500 | Rating Details | |
| 2023-06-16 14:21:16 -0500 | Rating Details | |
| 2023-06-16 14:08:25 -0500 | Rating Details | |
| 2023-06-16 14:07:33 -0500 | Rating Details | |
| 2023-06-16 14:06:38 -0500 | Rating Details | |
| 2023-06-16 14:05:50 -0500 | Rating Details | |
| 2023-06-16 13:59:21 -0500 | Rating Details | |
| 2023-06-16 13:53:57 -0500 | Rating Details | |
| 2023-06-16 13:28:46 -0500 | Rating Details | |
| 2023-06-16 13:06:05 -0500 | Rating Details | |
| 2023-06-16 12:41:11 -0500 | Rating Details | |
| 2023-06-16 12:30:05 -0500 | Rating Details | |
| 2023-06-16 12:26:46 -0500 | Rating Details | |
| 2023-06-16 10:12:10 -0500 | Rating Details | |
| 2023-06-16 09:44:03 -0500 | Rating Details | |
| 2023-06-16 08:46:39 -0500 | Rating Details | |
| 2023-06-16 07:54:29 -0500 | Rating Details | |
| 2023-06-16 07:53:31 -0500 | Rating Details | |
| 2023-06-16 07:53:05 -0500 | Rating Details | |
| 2023-06-19 09:10:08 -0500 | Rating Details | |
| 2023-06-24 15:28:28 -0500 | Rating Details | |
| 2023-08-22 17:05:19 -0500 | Rating Details | |
| 2023-08-22 16:06:40 -0500 | Rating Details | |
| 2023-08-22 15:49:45 -0500 | Rating Details | |
| 2023-08-22 15:46:33 -0500 | Rating Details | |
| 2023-08-22 15:14:49 -0500 | Rating Details | |
| 2023-08-23 13:55:08 -0500 | Rating Details | |
| 2023-08-23 07:09:15 -0500 | Rating Details | |
| 2023-08-23 02:09:20 -0500 | Rating Details | |
| 2023-08-23 02:02:15 -0500 | Rating Details | |
| 2023-08-24 08:04:19 -0500 | Rating Details | |
| 2023-09-03 14:21:23 -0500 | Rating Details | |
| 2023-10-18 04:59:59 -0500 | Rating Details | |
| 2024-02-27 07:51:30 -0600 | Rating Details | |
| 2024-08-23 00:42:10 -0500 | Rating Details | |
| 2024-08-22 16:51:22 -0500 | Rating Details |